NCT00723424View on ClinicalTrials.gov

Drug Interaction Study - Effect of AZD5672 on the Pharmacokinetics of Digoxin

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Healthy VolunteersPharmacokinetics

Interventions

DRUG

AZD5672

50 mg, for 13 days

DRUG

Digoxin

0.5mg dose

Trial Locations (1)

Unknown

Research Site, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY